BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 197 filers reported holding BEAM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $280 | -65.5% | 8,475 | -74.9% | 0.00% | -75.0% |
Q3 2023 | $812 | -99.9% | 33,781 | +32.6% | 0.01% | -55.6% |
Q1 2022 | $1,460,000 | +69.0% | 25,473 | +134.9% | 0.02% | +100.0% |
Q4 2021 | $864,000 | -29.9% | 10,843 | -28.2% | 0.01% | -25.0% |
Q4 2020 | $1,233,000 | – | 15,108 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MWG Management Ltd. | 2,346,934 | $74,937,603 | 45.33% |
HSG Holding Ltd | 796,089 | $25,419,122 | 2.91% |
Deep Track Capital, LP | 1,317,316 | $42,061,900 | 1.95% |
Redmile Group, LLC | 1,485,199 | $47,422,404 | 1.82% |
ARK Investment Management | 8,382,595 | $267,656,246 | 1.77% |
Casdin Capital, LLC | 570,000 | $18,200,100 | 1.59% |
Yiheng Capital Management, L.P. | 463,800 | $14,809,134 | 0.80% |
Temasek Holdings (Private) Ltd | 4,317,789 | $137,867,003 | 0.80% |
Alphabet Inc. | 321,604 | $10,268,815 | 0.55% |
FARALLON CAPITAL MANAGEMENT LLC | 3,441,522 | $109,887,797 | 0.55% |